Outcomes for Hand and Foot Soft Tissue Sarcomas Treated with Limb Sparing Multimodal Therapy

Overview

About this study

Goals:

Report and describe patient-reported functional outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
Describe radiotherapy volumes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
Report local control outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.
Report survival outcomes for hand and foot soft tissue sarcomas treated with limb sparing surgery and radiation therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

1) Patients must have a biopsy proven soft tissue sarcoma involving the hand or foot.

2) Patients must have received radiation therapy at Mayo Clinic, Rochester.

3) Age ≥18 years as of January 1, 2017.

Exclusion Criteria:

1) Absence of biopsy proven sarcoma involving the hand or foot.

2) Patients did not receive radiation therapy at Mayo Clinic, Rochester.

3) Age <18 years as of January 1, 2017.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Ivy Petersen, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Ivy Petersen, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials